Journal of Hematology and Oncology Research · ISSN 2372-6601
Editorial Board
The editors who assess submissions to this journal, with affiliations, countries, research interests, and available ORCID iDs provided for transparency.
- 63 Editors, including the Editor-in-Chief
- 23 Countries represented
- 49 Members with a public ORCID iD
- 30 Affiliations verified through ORCID
Membership and affiliations reviewed on 28 July 2026.
Editor-in-Chief
Krzysztof Roszkowski
Professor, Department of Oncology
Nicolaus Copernicus University Collegium Medicum
Bydgoszcz, Poland
Biomarkers of oxidative DNA damage; DNA damage and repair in cancer
Board members
Listed alphabetically by family name. Every entry gives the institution on record and links to the member’s full profile.
-
Muhamad Ramadan Abdel-Hameed Abdel-Nabi
Assiut University Faculty of Medicine
Internal Medicine Department · Assiut, Egypt
Clinical hematology; bone marrow transplantation
-
Simon Abi Aad
Icahn School of Medicine at Mount Sinai
New York, United States
Hematology-oncology; survivorship and treatment side effects
-
Bahram Alamdary Badlou
BBAdvies and Research
Head of Research and Development · Zeist, Netherlands
Platelets; transfusion and transplantation; cell therapy
-
John Allan
Weill Cornell Medical College
New York, United States
Plasma cell dyscrasias; leukemia; stem cell biology; coagulation
-
Almuradova Dilbar Muradovna
Assistant, Department of Oncology and Radiodiagnosis · Uzbekistan
Triple-negative breast cancer; medical oncology and radiology
-
Emmanuel Andres
Hôpitaux Universitaires de Strasbourg
Professor, Internal Medicine · Strasbourg, France
Cytopenias; anemia; thrombocytopenia; neutropenia; agranulocytosis
-
Wala Ben Kridis
Habib Bourguiba University Hospital
Associate Professor, Department of Oncology · Sfax, Tunisia
Medical oncology; chemotherapy; targeted therapy
-
Bachir Benarba
Thematic Research Agency in Health and Life Sciences
Director · Oran, Algeria
Natural products and apoptosis in cancer; phytochemistry
-
Vincenzo Canzonieri
University of Trieste
Associate Professor of Pathology · Trieste, Italy
Pathological anatomy; general oncology
-
Guo-Qiang Chen
Shanghai Jiao Tong University
Shanghai, China
Leukemia; hepatocellular carcinoma; cell differentiation and death
-
Saoussen Chouchene
Fattouma Bourguiba University Hospital
Hematology Department · Monastir, Tunisia
Hemostasis; immunohematology; hematology
-
Jonas Cicenas
Kauno Kolegija
Assistant Professor · Kaunas, Lithuania
Protein kinases in cancer; bioinformatics and biostatistics
-
Rafael Coveñas
University of Salamanca
Institute of Neurosciences of Castilla y Leon · Salamanca, Spain
NK-1 receptor and neuropeptides in cancer; immunocytochemistry
-
Shuaiying Cui
Boston University Chobanian & Avedisian School of Medicine
Hematology and Medical Oncology · Boston, United States
Acute myeloid leukemia; sickle cell disease; beta-thalassemia
-
Selçuk Demiral
Gülhane Training and Research Hospital
Department of Radiation Oncology · Turkey
Radiation oncology; radiotherapy; brachytherapy; radiosurgery; dosimetry
-
Wafik S. El-Deiry
Warren Alpert Medical School, Brown University
Associate Dean, Oncologic Sciences · Providence, United States
Molecular oncology; cancer molecular targets and therapeutics
-
Fernando Luiz Affonso Fonseca
Federal University of São Paulo (UNIFESP)
Head, Laboratory of Clinical Analysis, Faculdade de Medicina do ABC · Santo André, Brazil
Oncology
-
Marco Gambarotti
IRCCS Istituto Ortopedico Rizzoli
Pathological Anatomy and Histology · Bologna, Italy
Bone and soft-tissue tumors
-
Mazdak Ganjalikhani-Hakemi
Istanbul Medipol University
Associate Professor, Microbiology · Istanbul, Turkey
Cancer immunotherapy; RNA interference; immunology
-
Radu Bucur Gologan
Fundeni Clinical Institute
Hematology Department · Bucharest, Romania
Myelodysplastic syndrome; acute and chronic leukemias; lymphoma; anemias
-
Rada M. Grubovic
Council of Europe
Scientific Programme Manager, European Directorate for the Quality of Medicines · Strasbourg, France
Stem cell collection; transfusion medicine
-
Dumrul Gulen
Namik Kemal University
Department of Microbiology · Turkey
Tumor biology and immunology; dendritic cell vaccines
-
Seong-Su Han
University of Nebraska Medical Center
Assistant Professor, Pediatrics · Omaha, United States
Signal transduction in leukemia and lymphoma; chemoprevention
-
Michael Jaglal
H. Lee Moffitt Cancer Center and Research Institute
Tampa, United States
Hematology; leukemia; brain cancer
-
Iffat Jamal
Indira Gandhi Institute of Medical Sciences
Patna, India
Hematopathology; cytopathology; molecular cytogenetics; coagulation
-
Anup Kasi Loknath Kumar
University of Kansas Medical Center
United States
Gastrointestinal oncology; hematology
-
Goot Heah Khor
Universiti Teknologi MARA
Senior Lecturer, Centre of Preclinical Science Studies · Sungai Buloh, Malaysia
Oral oncology; cancer and molecular biology; histochemistry
-
Prasad S Koka
Biomedical Research Institute of Southern California
Oceanside, United States
Hematologic disease; hematopoietic stem cell transplantation; stem cell biology
-
José Pablo Leone
Dana-Farber Cancer Institute
United States
Brain metastases; male breast cancer; novel breast cancer therapies
-
Shulin Li
The University of Texas MD Anderson Cancer Center
Houston, United States
Immune therapy; gene therapy; circulating tumor cells
-
Houjie Liang
Third Military Medical University
Department of Oncology, Southwest Hospital · Chongqing, China
Mechanism, diagnosis and treatment of solid tumors
-
Hui Ling
The University of Texas MD Anderson Cancer Center
Houston, United States
MicroRNA and non-coding RNA; cancer epigenetics; genomic instability
-
Bashir A. Lwaleed
University of Southampton
Southampton, United Kingdom
Coagulation and thrombosis; cancer immunology; hematology
-
Guru Prasad Maiti
Oklahoma Medical Research Foundation
Assistant Staff Scientist, Arthritis and Clinical Immunology · Oklahoma City, United States
Cancer biology; RNA and gene expression; immunohistochemistry
-
Natalia Malara
Magna Graecia University of Catanzaro
Associate Professor · Catanzaro, Italy
Circulating tumor cells; early cancer detection; personalized oncologic therapy
-
Jayadev Manikkam Umakanthan
University of North Carolina Physician Network
United States
Leukemia, lymphoma and myeloma; breast and lung cancer
-
Ksenia Matlawska-Wasowska
University of Alabama at Birmingham
Associate Professor, Cell, Developmental and Integrative Biology · Birmingham, United States
Leukemia; immunobiology; cell biology
-
Hesham Mourad
Mayo Clinic Florida
Pharmacy Informatics Team Leader · Jacksonville, United States
Hematology and oncology pharmacy
-
Emmanuel Ifeanyi Obeagu
Kampala International University
Senior Lecturer, Department of Medical Laboratory Science · Uganda
Immunology of infectious disease; inflammation; flow cytometry
-
Vladimir Pak
Omega Alpha Pharmaceuticals
Research Scientist · United States
Molecular biology; APOBEC3; transcription
-
Nikolaos Panagiotopoulos
University College London Hospitals
London, United Kingdom
Lung cancer epidemiology; robotic thoracic surgery
-
Salvatore Papa
University of Leeds
Associate Professor, Leeds Institute of Medical Research · Leeds, United Kingdom
Cancer metabolism; inflammation and cell signaling
-
John Park
National Research Center Institute of Immunology, FMBA
Moscow, Russia
Immunology
-
Cesar A. Perez
University of Louisville
James Graham Brown Cancer Center · Louisville, United States
Malignant hematology; lymphoma and multiple myeloma; targeted therapy
-
Andreas Petzer
Barmherzige Schwestern Hospital Linz
Head, Internal Medicine I - Medical Oncology, Hematology and Gastroenterology · Linz, Austria
Chronic myeloid leukemia; stem cell biology
-
Xin Qing
Harbor-UCLA Medical Center
Head of Hematopathology; Director, Hematology and Flow Cytometry Laboratory · Torrance, United States
Hematopathology
-
Hassan Rafieemehr
Hamadan University of Medical Sciences
Department of Medical Laboratory Sciences · Hamadan, Iran
Stem cell biology and differentiation; flow cytometry; cell culture
-
Sunatee Sa-nguansai
Rajavithi Hospital
Oncology Unit, Department of Medicine · Bangkok, Thailand
Medical oncology
-
Benedetto Sacchetti
University of Turin
Turin, Italy
Skeletal stem cells; cell therapy
-
Yi Shan
University of Massachusetts Medical School
Worcester, United States
Leukemia stem cells; cancer gene therapy
-
Cees Smit Sibinga
University of Groningen
Professor of International Development of Transfusion Medicine · Groningen, Netherlands
Transfusion medicine; clinical hematology; immunohematology
-
Arun Srivastav
University of Florida College of Medicine
Division of Cellular and Molecular Therapy · Gainesville, United States
Adeno-associated viral gene therapy; hematology
-
Umit Tapan
Boston University School of Medicine
Assistant Professor, Internal Medicine · Boston, United States
Cancer biomarker research
-
Venu Thirukonda
Billings Clinic Cancer Center
Billings, Montana, United States
Hematologic malignancies; lung cancer
-
Erxi Wu
North Dakota State University
Department of Pharmaceutical Sciences · Fargo, United States
Tumor therapeutic targets; drug discovery; biomarkers
-
Hehuang Xie
Virginia Polytechnic Institute and State University
Professor, Biomedical Sciences and Pathobiology · Blacksburg, United States
DNA methylation; epigenetics of complex disease
-
Zheng Xu
Columbia University in the City of New York
Associate Research Scientist · New York, United States
Tumor immunology; microRNA and carcinogenesis
-
Hadi Yaziji
Vitro Molecular Laboratories
United States
Cancer translational research
-
Xingding Zhang
Sun Yat-sen University
Professor and Assistant Dean, School of Medicine · Shenzhen, China
Lymphoma; myeloma
-
Xinyang Zhao
The University of Kansas Medical Center
Associate Professor, Pathology and Laboratory Medicine · Kansas City, United States
Chromatin biology; arginine methylation
-
Zilu Zhu
Sanford Burnham Prebys Medical Discovery Institute
Tumor Microenvironment and Cancer Immunology Program · La Jolla, United States
B-cell signaling; Fc receptors; inflammation
-
Agnieszka Żyromska
Franciszek Łukaszczyk Oncology Center
Department of Radiotherapy · Bydgoszcz, Poland
Radiation biology; pediatric cancers; tumor hypoxia; cancer biomarkers
Where this board’s expertise sits
Before submitting, most authors want one thing answered: is there anyone here who can actually review my manuscript? These figures are counted from the members' own recorded research interests each time the page loads.
- Cancer biology, genomics and epigenetics25
- Pathology, diagnostics and biomarkers19
- Immunotherapy, cell and gene therapy19
- Clinical and solid tumor oncology18
- Leukemia, lymphoma and myeloma13
- Hematology, hemostasis and transfusion12
- Radiation oncology3
Members are counted in every area their recorded interests match, so these figures sum to more than the size of the board. If your subject is not represented here, the honest answer is that this is not the right journal for the manuscript — the aims and scope set out what is in and out of scope.
What the board is responsible for
Each statement below is taken from the journal's own published policy, and names the page it comes from.
-
What an editor decides
Editors are described by the journal as scientific stewards responsible for rigor, integrity, and patient relevance, applying consistent standards across study designs, clinical settings, and geographic contexts.
Initial screening covers scope alignment, the quality of the title and abstract, and whether the work adds knowledge beyond an incremental or redundant analysis. A manuscript is rejected when it is out of scope, methodologically flawed, or lacks clinical relevance.
Source: Editor Guidelines -
How review is organized
Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts.
Revisions are assessed by comparing the authors' responses against the reviewers' comments. Appeals are handled with a documented rationale and, where needed, further independent review.
Source: Editorial Policies -
Ethics and competing interests
Editors require conflict-of-interest disclosure, funding statements and author contribution details, and screen for plagiarism, duplicate publication and image manipulation.
JHOR follows COPE guidance on suspected misconduct: editors document the evidence, consult editorial leadership, and follow the established investigation protocol. Corrections, expressions of concern and retractions are issued under the same guidance.
Source: Editorial Policies · Editor Guidelines
How a manuscript is reviewed
- Review model
- Single-blind (double-blind on request)
- External peer review
- Normally at least two independent subject-matter experts
- Ethics framework
- COPE and ICMJE guidance; iThenticate similarity screening
Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal. Board membership confers no advantage in review or acceptance. See the editorial policies and article processing charges.
Submitting to JHOR
The 63 articles this journal has published since 2014 were assessed by the editors listed above. If your work sits inside the scope, the author instructions set out the submission route and the manuscript requirements in full.